Abstract
Background: Hemostatic disturbances with coronavirus disease
2019 (COVID-19) can predispose to tricuspid and right heart thrombi in
very rare instances. Aim: We describe a 29-year-old female
patient without previous cause of thrombosis who developed large
tricuspid valve thrombus (TVT) and moderate-to-severe tricuspid
regurgitation (TR) during the course of COVID-19 infection.
Materials and methods: Persistant fever and tachycardia with
thrombocytopenia and high D-dimer increased the index of suspicion. The
diagnosis was made by bedside transthoracic echocardiography (TTE) and
cardiac magnetic resonance (CMR). Surgery was performed for thrombectomy
and tricuspid valve replacement with a tissue valve. Discussion
and conclusion: Detection of TVT in COVID-19 patients on the basis of
high index of suspicion, bedside TTE and non-invasive CMR helps early
surgical treatment and subsequent reduction of mortality and hospital
stay.